Patient info

Femiloges gastro-resistant tablets – patient leaflet, side effects, dosage

Updated:

Patient leaflet - Femiloges gastro-resistant tablets

1. What Femiloges is and what it is used for

This medicine contains a dry extract of Rhapon-

tic rhubarb root. It is a traditional herbal medicinal

product used for the relief of symptoms of the me-

nopause, such as hot flushes/sweats, sleep distur-

bances, slightly low mood and mild anxiety, based

on traditional use only. As there is evidence that

Rhapontic rhubarb may have hormone-like actions,

it should only be used by women of childbearing age

if contraception is used.

2. What you need to know before you take Femiloges

Do not take Femiloges if:

you are allergic to Rhapontic rhubarb root

or any of the other ingredients of this medicine

(listed in section 6)

you are pregnant, think you may be pregnant

or are breast-feeding

you are of childbearing age and not using con-

traception

you are under 18 years old

you have unexplained vaginal bleeding

you are or have been treated for breast cancer or

other hormone-dependent tumours

you are taking oestrogen-containing medicines

(e.g hormonal contraceptives, hormone replace-

ment therapy) unless your doctor advises that it

is safe to do so

Warnings and precautions

If you have a peristant history of menstrual disorders, consult your doctor before taking this medicine.

If unexpected bleeding occurs or you notice any re-appearance or changes in menstrual bleeding, consult your doctor. It may be signs of conditions that require medical examina-tions by a doctor.

This medicine is intended for relief of meno-pausal symptoms including slightly low mood and mild anxiety. Patients with signs and sym-ptoms of depression should consult a doctor for appropriate treatment.

Children and adolescents

This medicine is not to be used in children and adolescents under 18 years old.

Other medicines and Femiloges

Tell your doctor, pharmacist or qualified healthcare practitioner if you are taking, have recently taken or might take any other medicines.

Do not take this medicine together with oestrogen-containing medicines (e.g. hormonal contracep-tives, hormone replacement therapy) unless your doctor advises it is safe to do so.

If Femiloges is taken at the same time as medicines that are known as antacids, the gastro-resistant film-coating of Femiloges may be dissolved prematurely. Therefore, Femiloges and antacids should be taken at least 1 hour apart.

Pregnancy and breast-feeding

Femiloges should not be used during pregnancy and breast-feeding. For women of child bearing age, Femiloges should not be used without contraception. Driving and using machines

This medicine has no known influence on the ability to drive and use machines.

Femiloges contains lactose, sucrose and sodium

Femiloges contains lactose and sucrose. If you have been told by your doctor that you have an intoleran-Femiloges gastro-resistant tablets is referred to as “Femiloges” throughout this package leaflet.

1.3.2.UK.6 pl-initial-maa-rtq5 rheum root THMP UK

gastro-resistant tablet August 2026

0006 page 1

ce to some sugars, contact your doctor before taking this medicine. This medicine contains less than 1 mmol sodium (23 mg) per gastro-resistant tablet, that is to say essentially ‘sodium-free’.

3. How to take Femiloges

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or qualified healthcare practitioner has told you. Check with your doctor, pharmacist or qualified healthcare practitioner if you are not sure.

Adult women experiencing menopausal symptoms

The recommended dose is 1 gastro-resistant tablet of Femiloges once daily. Do not take more than the label/leaflet tells you to take.

This medicine is not for use in children or adolescents under 18 years old.

Method of administration

Do not crush or chew the tablets. Femiloges should be swallowed whole with a sufficient amount of liquid (e.g. a glass of water), ideally at the same time each day. Take it at least half an hour before breakfast or 1 - 2 hours before a meal. Duration of administration

You must talk to a doctor, pharmacist or qualified healthcare practitioner if you feel worse, or do not feel better after 3 months. You must not take Femiloges for more than 6 months without medical advice. If you take more Femiloges than you should

No cases of overdose have been reported. How-ever if you take more than the recommended dose and you feel unwell, speak to your doctor, pharma-cist or qualified healthcare practitioner and take this leaflet with you.

If you forget to take Femiloges

If you forget to take Femiloges and it is within 12 hours of your usual dose, take the forgotten dose as soon as you remember. If you remember the for-gotten dose after more than 12 hours, you should not take the missed dose. Wait until your next usual dose is due and take it then. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Femiloges

You do not have to take any special measures. If the symptoms mentioned in section 2, “Warnings and precautions” occur, you should consult your doctor, pharmacist or qualified healthcare practiti-oner. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or qualified healthcare practitioner.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur:

Gastrointestinal symptoms such as

nausea

stomach ache

flatulence

diarrhoea

Headache

Allergic (hypersensitivity) reactions such as

reddening of the skin

Femiloges

gastro-resistant tablets

certification mark ganz m

eine Natur

1.3.2.UK.6 pl-initial-maa-rtq5 rheum root THMP UK

gastro-resistant tablet August 2026

0006 page 2

skin rash

swelling of the skin (also in the face) itching

The frequency that these effects may occur is not known.

Reporting of side effects

If you get any side effects, talk to your doctor, phar-macist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this me-dicine.

5. How to store Femiloges

Keep this medicine out of the sight and reach of children. Do not store this medicine above 30 °C. Store in the original packaging.

Do not use this medicine after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Femiloges contains

Each gastro-resistant tablet contains 4 mg of extract (as dry extract) from Rhapontic rhubarb root (Rheum rhaponticum L., radix) (DER 16-26:1)

Extraction solvent: aqueous solution of calcium oxide (calcium oxide: water ratio 1:38 (m/m)).

The other ingredients are calcium carbonate, carnauba wax, beeswax white, lactose monohydrate, macrogol (6 000), macrogol (35 000), magnesium stearate, methacrylic acid – methyl methacrylate copolymer (1:1), microcrystalline cellulose, sodium laurilsulfate, povidone K25, povidone K90, sucrose, talc, triethyl citrate.

What Femiloges looks like and contents of the pack

White, round, biconvex gastro resistant tablet. Femiloges is available in packs of 30, 50, 60, 90 and 100 tablets.

Not all pack sizes may be marketed.

Traditional Herbal Registration

Holder and Manufacturer

Dr. Loges + Co. GmbH

Schützenstraße 5

21423 Winsen (Luhe)

Germany

This leaflet was last revised in 08/2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: THR455080001

Last revision stated in the text: August 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Femiloges gastro-resistant tablets

Marketing authorisation THR 45508/0001

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.